In conclusion, we have identified aberrant expression of IDO in GAC as an independent prognosticator, which could be incorporated with depth of tumor invasion and lymph node metastasis status to generate a nomogram to give a better stratification for patients with different prognosis. This evidence concerns the gene IDO1 and metastatic malignant neoplasm in the lymph nodes.